loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Bictegravir Sodium

    Menu

    Bictegravir Sodium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 450Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 210251 / DOSAGE - TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BICTEGRAVIR SODIUM(UNII: 4L5MP1Y7W7)
    (BICTEGRAVIR - UNII:8GB79LOJ07)     		BICTEGRAVIR30mg | 50mg
    EMTRICITABINE(UNII: G70B4ETF4S)
    (EMTRICITABINE - UNII:G70B4ETF4S)     		EMTRICITABINE120mg | 200mg
    TENOFOVIR ALAFENAMIDE FUMARATE(UNII: FWF6Q91TZO)
    (TENOFOVIR ANHYDROUS - UNII:W4HFE001U5)     		TENOFOVIR ANHYDROUS15mg | 25mg

    Inactive Ingredients

    Ingredient Name
    Gilead Sciences, Inc.
    CROSCARMELLOSE SODIUM(M28OL1HH48)
    FERRIC OXIDE RED(1K09F3G675)
    FERROSOFERRIC OXIDE(XM0M87F357)
    MAGNESIUM STEARATE(70097M6I30)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
    POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
    POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990)
    TALC(7SEV7J4R1U)
    TITANIUM DIOXIDE(15FIX9V2JP)
    WATER(059QF0KO0R)